Independent guide to NAD+ injections
NAD IV vs injection: how clinic drips and telehealth injections differ in setting, supervision, side effect reports and cost, and what the evidence says.
Physician-guided NAD+ injection kit from a licensed telehealth platform. Includes online consultation.
NAD+ research peptide in a multi-dose vial. Independent lab tested with COA published per lot. Ships from US stock.
Compounded NAD+ nasal spray from a telehealth platform. Needle-free delivery with physician oversight.
| Product | Form | Access | Shipping | Testing | Reviews | Price |
|---|---|---|---|---|---|---|
| Arc-1 NAD+ Injections | Injectable (compounded) | Telehealth + Rx | Direct to door | — | — | $299.99 |
| Real Peptides NAD+ Peptide (Multi-Dose Vial) | Lyophilized powder | — | US stock | Third-party COA | — | $60.00 |
| Arc-1 NAD+ Nasal Spray | Nasal spray (compounded) | Telehealth + Rx | Direct to door | — | 1 | $149.99 |
The reactions clinics most often report with NAD+, namely flushing, nausea, chest tightness and cramping, are linked to IV infusions given fast, and that single fact shapes most of the NAD IV vs injection question. An IV drip delivers NAD+ into a vein over a supervised session in a clinic chair. An injection is a much shorter event, offered by clinics and, through telehealth prescribers such as Arc-1 at $299.99, as a compounded product shipped to your door.
Below I compare the two on setting, supervision, cost and evidence. Neither route uses an FDA-approved NAD+ product, and this is not medical advice.
The practical difference is time, place and who is present. This table sets out the main contrasts.
| Factor | NAD+ IV drip | NAD+ injection |
|---|---|---|
| Where | Clinic or med-spa | Clinic, or via a telehealth prescription |
| Session length | Long, staff sets the infusion rate | Short |
| Supervision | Staff present throughout | Clinic staff, or prescriber oversight for telehealth |
| Price visibility | Set by each clinic | Arc-1 lists $299.99 |
| FDA status | Not an approved NAD+ drug | Not an approved NAD+ drug |
The speed of an IV can be adjusted by staff, which is how clinics respond when someone starts flushing or feeling nauseous. That control is a real advantage of the drip setting.
Most published clinic reports of NAD+ side effects concern IV infusions, where a fast rate is associated with flushing, nausea, chest tightness and cramping. Fewer reports address injections, but that is a gap in reporting rather than proof injections are free of reactions.
Comparing safety by route needs controlled human studies, and those have not been done for injectable NAD+ in the facts we work from. What we can say is that both routes involve introducing a compound that is not FDA-approved, and both are safer with a clinician involved. The side effects page lists what to watch for.
IV pricing is set clinic by clinic, and a drip occupies a chair, a nurse and a longer block of time, all of which clinics build into the session price. Clinics do not publish a national standard, so the only firm number we can give is the telehealth one: Arc-1's NAD+ Injections at $299.99, including a physician consultation, with 30-day returns.
When comparing, ask each clinic for its full per-session price and how many sessions it usually recommends. Our NAD injections cost guide breaks down telehealth and research pricing in more detail.
No controlled human trial shows that NAD+ by IV produces better outcomes than NAD+ by injection, or the reverse. Human evidence for injectable NAD+ benefits overall is limited, and most strong data come from cells and animals. Claims that "IV is the only route that works" or that "injections are just as good" are both opinions.
We think the more useful question is which setting gives you the supervision you need. A person with a complex medical history may prefer a clinic where staff can stop an infusion. Someone weighing a home program will want to understand how telehealth prescribing works, which we describe on NAD injections at home.
The NAD IV vs injection decision is easier once a few personal questions are answered, ideally with your doctor:
We find that people who answer these first rarely end up choosing on price alone, which is the right outcome given how little separates the routes on evidence.
Research vials do not fit the NAD IV vs injection decision at all, because they are not sold for human use. Real Peptides' NAD+ Peptide (Multi-Dose Vial) at $60.00 is a lyophilized research compound with a third-party COA, labelled research use only and not for human consumption, with no physician consultation.
FDA's August 2026 warning letters to five online peptide vendors showed that the agency looks at the whole website, and treats dosing guidance and bacteriostatic water sold alongside injectables as signs of intended human use. For anyone deciding between a drip and an injection for themselves, the choice is between two medical routes, and the person to make it with is your doctor.
The reactions clinics most often report with NAD+, namely flushing, nausea, chest tightness and cramping, are linked to IV infusions given fast, and that single fact shapes most of the NAD IV vs injection question. An IV drip delivers NAD+ into a vein over a supervised session in a clinic chair. An injection is a much shorter event, offered by clinics and, through telehealth prescribers such as Arc-1 at $299.99, as a compounded product shipped to your door.
Below I compare the two on setting, supervision, cost and evidence. Neither route uses an FDA-approved NAD+ product, and this is not medical advice.
The practical difference is time, place and who is present. This table sets out the main contrasts.
| Factor | NAD+ IV drip | NAD+ injection |
|---|---|---|
| Where | Clinic or med-spa | Clinic, or via a telehealth prescription |
| Session length | Long, staff sets the infusion rate | Short |
| Supervision | Staff present throughout | Clinic staff, or prescriber oversight for telehealth |
| Price visibility | Set by each clinic | Arc-1 lists $299.99 |
| FDA status | Not an approved NAD+ drug | Not an approved NAD+ drug |
The speed of an IV can be adjusted by staff, which is how clinics respond when someone starts flushing or feeling nauseous. That control is a real advantage of the drip setting.
Most published clinic reports of NAD+ side effects concern IV infusions, where a fast rate is associated with flushing, nausea, chest tightness and cramping. Fewer reports address injections, but that is a gap in reporting rather than proof injections are free of reactions.
Comparing safety by route needs controlled human studies, and those have not been done for injectable NAD+ in the facts we work from. What we can say is that both routes involve introducing a compound that is not FDA-approved, and both are safer with a clinician involved. The side effects page lists what to watch for.
IV pricing is set clinic by clinic, and a drip occupies a chair, a nurse and a longer block of time, all of which clinics build into the session price. Clinics do not publish a national standard, so the only firm number we can give is the telehealth one: Arc-1's NAD+ Injections at $299.99, including a physician consultation, with 30-day returns.
When comparing, ask each clinic for its full per-session price and how many sessions it usually recommends. Our NAD injections cost guide breaks down telehealth and research pricing in more detail.
No controlled human trial shows that NAD+ by IV produces better outcomes than NAD+ by injection, or the reverse. Human evidence for injectable NAD+ benefits overall is limited, and most strong data come from cells and animals. Claims that "IV is the only route that works" or that "injections are just as good" are both opinions.
We think the more useful question is which setting gives you the supervision you need. A person with a complex medical history may prefer a clinic where staff can stop an infusion. Someone weighing a home program will want to understand how telehealth prescribing works, which we describe on NAD injections at home.